share_log

Short Interest in British American Tobacco P.l.c. (NYSE:BTI) Expands By 17.3%

Financial News Live ·  Oct 3, 2022 21:33

British American Tobacco p.l.c. (NYSE:BTI – Get Rating) saw a significant increase in short interest in September. As of September 15th, there was short interest totalling 2,240,000 shares, an increase of 17.3% from the August 31st total of 1,910,000 shares. Based on an average daily volume of 2,540,000 shares, the days-to-cover ratio is presently 0.9 days.

British American Tobacco Price Performance

BTI traded up $1.09 during midday trading on Monday, reaching $36.59. 3,247,145 shares of the company's stock traded hands, compared to its average volume of 3,511,433. The firm has a fifty day moving average of $39.66 and a two-hundred day moving average of $41.55. The company has a current ratio of 0.88, a quick ratio of 0.52 and a debt-to-equity ratio of 0.54. British American Tobacco has a 52 week low of $33.62 and a 52 week high of $47.24.

Get British American Tobacco alerts:

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. Fifth Third Bancorp grew its holdings in shares of British American Tobacco by 4.1% during the 1st quarter. Fifth Third Bancorp now owns 29,030 shares of the company's stock worth $1,224,000 after acquiring an additional 1,155 shares during the period. Exane Derivatives purchased a new position in shares of British American Tobacco during the 1st quarter worth approximately $261,000. FDx Advisors Inc. grew its stake in shares of British American Tobacco by 0.8% in the 1st quarter. FDx Advisors Inc. now owns 64,475 shares of the company's stock worth $2,718,000 after buying an additional 518 shares during the last quarter. Ameritas Advisory Services LLC purchased a new stake in shares of British American Tobacco in the 1st quarter worth approximately $221,000. Finally, Cambridge Investment Research Advisors Inc. grew its stake in shares of British American Tobacco by 1.5% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 83,429 shares of the company's stock worth $3,517,000 after buying an additional 1,264 shares during the last quarter. Hedge funds and other institutional investors own 6.70% of the company's stock.

Analyst Ratings Changes

Several equities research analysts have issued reports on the company. StockNews.com raised British American Tobacco from a "hold" rating to a "buy" rating in a research note on Friday. Barclays boosted their target price on British American Tobacco from GBX 4,200 ($50.75) to GBX 4,400 ($53.17) in a research note on Tuesday, June 7th. Finally, Morgan Stanley boosted their target price on British American Tobacco from GBX 3,780 ($45.67) to GBX 4,000 ($48.33) in a research note on Tuesday, July 5th.

British American Tobacco Company Profile

(Get Rating)

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers worldwide. It offers vapour, tobacco heating, and modern oral nicotine products; combustible products; and traditional oral products, such as snus and moist snuff. The company offers its products under the Kent, Dunhill, Lucky Strike, Pall Mall, Rothmans, Camel, Newport, Natural American Spirit, being Vapour, THP, and Modern Oral brands.

See Also

  • Get a free copy of the StockNews.com research report on British American Tobacco (BTI)
  • Near-Term Headwinds Send Nike To The Bargain Basement
  • Archer Daniels Midland: Dividend Hero With 49 Years Of Increases
  • Will Fully Autonomous Tractors Make Deere the Tesla of Farming?
  • Magna International is Your Auto and EV One-Stop Shop Stock
  • Is the Bond Market Signaling a Market Bottom?

Receive News & Ratings for British American Tobacco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for British American Tobacco and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment